Clinical Trials on Polmonite eosinofila cronica

Total 23894 results

Parker Research Institute
Oak Foundation; Rehabilitation Center Rødovre Municipality (Genoptræning Rødovre... and other collaborators

Recruiting

Group-based [ADAPT] Versus One-to-one [Usual] Occupational Therapy (Go:OT Trial) (Go:OT)

Chronic Disease | Chronic Conditions, Multiple | Chronic Condition

Denmark
Parker Research Institute
Oak Foundation; Rehabilitation Center Rødovre Municipality (Genoptræning Rødovre... and other collaborators

Active, not recruiting

Group-based [ADAPT] Versus One-to-one [Usual] Occupational Therapy (Go:OT)

Chronic Conditions, Multiple | Chronic Condition

Denmark
University of Alabama at Birmingham

Recruiting

An Accessible and Inclusive Artificial Intelligence Assisted Chronic Disease Self-Management Telehealth Platform

Disability Physical | Chronic Conditions, Multiple | Chronic Condition

United States
Radboud University Medical Center

Recruiting

EMBOSS A Person-centred Integrated-care for Chronic Diseases in Patients of Low Socio Economic Status (EMBOSS)

Chronic Conditions, Multiple | Chronic Condition

Netherlands
Documenting Hope Project

Recruiting

FLIGHT Study for Childhood Chronic Illness

Chronic Illnesses, Multiple

United States
American Academy of Family Physicians
University of Colorado, Denver; National Institute of Diabetes and Digestive... and other collaborators

Completed

Improving Evidence-Based Primary Care for Chronic Kidney Disease

Chronic Kidney Disease | Chronic Renal Insufficiency | Chronic Kidney Insufficiency | Chronic Renal Diseases | Kidney Insufficiency, Chronic

United States
Korean Society of Hematology

Not yet recruiting

A Study of Treatment-free Remission in Chronic Phase Chronic Myeloid Leukemia (AsterA)

Chronic Myeloid Leukemia, Chronic Phase
University of California, Irvine

Recruiting

Impact of Personality on Adherence to Tyrosine Kinase Inhibitor Therapy in Pts w/Chronic Myeloid Leukemia

Chronic Myeloid Leukemia | Chronic Phase Chronic Myelogenous Leukemia

United States
National Cancer Institute (NCI)

Completed

Oblimersen and Imatinib Mesylate in Treating Patients With Chronic Myelogenous Leukemia

Chronic Phase Chronic Myelogenous Leukemia | Relapsing Chronic Myelogenous Leukemia | Chronic Myelogenous Leukemia, BCR-ABL1 Positive

United States
National Cancer Institute (NCI)

Completed

Imatinib Mesylate in Treating Patients With Chronic Myelogenous Leukemia

Childhood Chronic Myelogenous Leukemia | Chronic Phase Chronic Myelogenous Leukemia | Chronic Myelogenous Leukemia, BCR-ABL1 Positive

United States
H. Lee Moffitt Cancer Center and Research Institute
Incyte Corporation; H. Jean Khoury Cure CML Consortium

Recruiting

Treatment Free Remission After Combination Therapy With Ruxolitinib Plus Tyrosine Kinase Inhibitors

Chronic Myeloid Leukemia, Chronic Phase | Chronic Phase Chronic Myeloid Leukemia

United States
Universiti Putra Malaysia

Recruiting

Validation and Evaluation of a Newly Developed Mobile Diet App

Chronic Kidney Diseases | Chronic Kidney Disease Stage 5 | Chronic Kidney Disease stage4 | Chronic Kidney Disease stage3 | Chronic Kidney Disease Requiring Chronic Dialysis

Malaysia
National Cancer Institute (NCI)

Completed

Homoharringtonine in Treating Patients With Chronic Phase Chronic Myelogenous Leukemia

Childhood Chronic Myelogenous Leukemia | Chronic Phase Chronic Myelogenous Leukemia | Relapsing Chronic Myelogenous Leukemia | Chronic Myelogenous Leukemia, BCR-ABL1 Positive

United States
University of the State of Santa Catarina

Unknown

Neuromuscular Electrical Stimulation During Hemodialysis in Peripheral Muscle Strength and Exercise Capacity

Kidney Diseases | Chronic Kidney Diseases | Hemodialysis | Chronic Renal Insufficiency | Renal Dialysis | Chronic Kidney Insufficiency | Chronic Renal Diseases

Brazil
Medical College of Wisconsin
H. Jean Khoury Cure CML Consortium

Recruiting

Protocol Number: HJKC3-0003. Treatment Free Remission After Combination Therapy With Asciminib (ABL001) Plus Tyrosine Kinase Inhibitors (TKI) in Chronic Phase Chronic Myeloid Leukemia (CP-CML) Patients Who Relapsed After a Prior Attempt at TKI Discontinuation

Chronic Phase Chronic Myelogenous Leukemia

United States
3-C Institute for Social Development
University of North Carolina, Chapel Hill

Completed

Living With CKD: An E-Learning Platform for Adolescents With CKD About the Disease and Its Management (CKD Delp)

Chronic Kidney Diseases | Chronic Kidney Disease Stage 5 | Chronic Kidney Disease stage4 | Pediatric Kidney Disease | Chronic Kidney Disease stage3 | Chronic Kidney Disease Stage V | Chronic Kidney Disease, Stage IV (Severe) | Chronic Kidney Disease Stage 2 | Chronic Kidney Disease, Stage I

United States
Asan Medical Center

Terminated

Chronic Myelod Leukemia Registry at Asan Medical Center

Leukemia, Chronic Myeloid | Myeloid Leukemia, Chronic, Chronic Phase | Myeloid Leukemia, Chronic, Accelerated Phase

Korea, Republic of
University Hospital Tuebingen

Unknown

Balloon Angioplasty Versus Xpert Stent in CLI Patients XXS Study (XXS)

Intervention | Cronic Limb Ishemia

Germany
Pain Concern
The Thistle Foundation; Health and Social Care Alliance Scotland (the ALLIANCE) and other collaborators

Completed

Supporting Self-management of Chronic Pain

Chronic Pain | Chronic Pain Syndrome | Chronic Pain, Widespread | Chronic Pain Due to Trauma | Chronic Pain Due to Malignancy (Finding) | Chronic Pain Due to Injury | Chronic Pain Post-Procedural | Chronic Pain Hip

United Kingdom
Fundacion Espanola para la Curacion de la Leucemia...
Pfizer; Roche Farma, S.A

Terminated

Safety and Efficacy Evaluation of Bosutinib Plus Atezolizumab in Newly Diagnosed Chronic Leukemia Adult Patients

Chronic Phase-Chronic Myeloid Leukemia

Spain
Takeda

Active, not recruiting

Ponatinib in Participants With Resistant Chronic Phase Chronic Myeloid Leukemia (CP-CML) to Characterize the Efficacy and Safety of a Range of Doses (OPTIC)

Myeloid Leukemia, Chronic, Chronic Phase

United States, Spain, Taiwan, Australia, Canada, Russian Federation, Sweden, Switzerland, Germany, United Kingdom, Poland, Korea, Republic of, Argentina, Hong Kong, Singapore, Italy, Chile, Czechia, Denmark, France, Portugal
Children's Oncology Group
National Cancer Institute (NCI)

Recruiting

Stopping Tyrosine Kinase Inhibitors in Affecting Treatment-Free Remission in Patients With Chronic Phase Chronic Myeloid Leukemia

Chronic Phase Chronic Myeloid Leukemia, BCR-ABL1 Positive

United States, Canada, Australia, Puerto Rico
National Cancer Institute (NCI)

Terminated

Dasatinib and Cyclosporine in Treating Patients With Chronic Myelogenous Leukemia Refractory or Intolerant to Imatinib Mesylate

Accelerated Phase Chronic Myelogenous Leukemia | Chronic Phase Chronic Myelogenous Leukemia | Relapsing Chronic Myelogenous Leukemia | Chronic Myelogenous Leukemia, BCR-ABL1 Positive

United States
Newcastle University
Bristol-Myers Squibb; Institute of Cancer Research, United Kingdom; Newcastle-upon-Tyne... and other collaborators

Completed

Comparison of Imatinib Versus Dasatinib in Patients With Newly-diagnosed Chronic Phase Chronic Myeloid Leukaemia (SPIRIT2)

Myeloid Leukemia, Chronic, Chronic Phase

United Kingdom
Assistance Publique - Hôpitaux de Paris

Recruiting

Evaluation of Human Papillomavirus Vaccine Coverage in Girls and Young Women With Chronic Disease (MC-HPV)

Human Papillomavirus Vaccine | Chronic Condition

France
University of Colorado, Denver
National Institute on Aging (NIA)

Completed

Social Convoy Palliative Care (Convoy-Pal) Mobile Health for Older Adults (ConvoyPal)

Chronic Conditions, Multiple

United States
Weill Medical College of Cornell University

Completed

Assessing Costs & Cost-variability Among Enrollees of Health Insurance Programs Utilizing Charlson's Comorbidity Index and Administrative Databases

Multiple Chronic Illnesses

United States
National Cancer Institute (NCI)

Completed

Homoharringtonine Plus Low-Dose Cytarabine in Treating Patients With Newly Diagnosed Chronic Myelogenous Leukemia in Chronic Phase

Chronic Phase Chronic Myelogenous Leukemia | Chronic Myelogenous Leukemia, BCR-ABL1 Positive

United States
Children's Oncology Group
Pfizer; Erasmus Medical Center; Dutch Childhood Oncology Group; Innovative Therapies...

Active, not recruiting

Bosutinib in Pediatric Patients With Newly Diagnosed Chronic Phase or Resistant/Intolerant Ph + Chronic Myeloid Leukemia

Accelerated Phase Chronic Myelogenous Leukemia | Chronic Phase Chronic Myelogenous Leukemia | Blastic Phase Chronic Myelogenous Leukemia | Philadelphia Chromosome Positive CML

United States
Innovation Research & Training

Completed

Website for Adolescents About Pediatric Clinical Trials

Healthy | Chronic Illnesses, Multiple

United States
National Cancer Institute (NCI)

Terminated

Temsirolimus and Imatinib Mesylate in Treating Patients With Chronic Myelogenous Leukemia

Accelerated Phase Chronic Myelogenous Leukemia | Chronic Phase Chronic Myelogenous Leukemia | Relapsing Chronic Myelogenous Leukemia | Chronic Myelogenous Leukemia, BCR-ABL1 Positive | Blastic Phase Chronic Myelogenous Leukemia

United States
Radboud University Medical Center

Recruiting

OPTIMA FORMA Phase 3 (OPTIMAFORMA3)

Chronic Conditions, Multiple | Chronic Condition

Netherlands
National Heart, Lung, and Blood Institute (NHLBI)

Active, not recruiting

Ibrutinib, Fludarabine, and Pembrolizumab in High-Risk or Relapsed/Refractory Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma

Leukemia, Lymphocytic, Chronic, B-Cell | Chronic Lymphocytic Leukemia | Leukemia, Chronic Lymphatic | B-Cell Chronic Lymphocytic Leukemia | Leukemia, Lymphocytic, Chronic | B-Lymphocytic Leukemia, Chronic | Leukemia, Chronic Lymphocytic, B-Cell | Lymphocytic Leukemia, Chronic, B Cell | Lymphocytic Leukemia...

United States
Thomas Jefferson University

Completed

A Mobile Intervention (txt4TKI) for the Improvement of Tyrosine Kinase Inhibitor Management in Patients With Chronic Myeloid Leukemia

Chronic Phase Chronic Myelogenous Leukemia | Chronic Myelogenous Leukemia, BCR-ABL1 Positive

United States
Assiut University

Unknown

Chronic Myloid Leukemic Patients Treated With Tyrosine Kinase Inhibitor

Chronic Phase Chronic Myelogenous Leukemia
Hikma Pharmaceuticals LLC

Completed

Low Dose Dasatinib (50 mg Daily) as First-line Treatment for Newly Diagnosed Chronic-Phase Chronic Myeloid Leukemia

Chronic Myelogenous Leukemia

Jordan, Lebanon, Saudi Arabia, Tunisia
Children's Hospital Los Angeles
Organon

Recruiting

Perceptions of LARC Among AYA With Chronic Illness (LARC)

Chronic Conditions, Multiple

United States
Centre Hospitalier le Mans
Le Mans Universite

Recruiting

Physiopathology of Neuromuscular Function Related to Fatigue in Chronic Renal Disease (PIONEER)

Fatigue | Chronic Kidney Disease Stage 5 | Chronic Kidney Disease stage4 | Chronic Kidney Disease Stage 3B

France
University of Pittsburgh
National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)

Recruiting

Pancreatic Quantitative Sensory Testing (P-QST) to Predict Treatment Response for Pain in Chronic Pancreatitis (P-QST)

Chronic Pain | Chronic Pancreatitis

United States
University of Utah

Recruiting

Deep Brain Therapy With Low-intensity Ultrasound for Generalized Chronic Pain (DBT)

Chronic Pain | Chronic Pain Syndrome | Widespread Chronic Pain

United States
University of Wisconsin, Madison
National Heart, Lung, and Blood Institute (NHLBI)

Recruiting

ElderTree Via a Voice Activated Device for Managing Chronic Health Conditions (NHLBI)

Chronic Conditions, Multiple

United States
Innovation Research & Training

Completed

Web-based Resource for Children and Adolescents About Clinical Research

Healthy | Chronic Illnesses, Multiple

United States
VA Office of Research and Development

Recruiting

Novel Cellular Therapy for the Treatment of Pain Associated With Chronic Pancreatitis (MSCPainRelief)

Chronic Pain | Chronic Pancreatitis

United States
M.D. Anderson Cancer Center
National Cancer Institute (NCI)

Active, not recruiting

Dasatinib in Treating Patients With Early Chronic Phase Chronic Myelogenous Leukemia

Chronic Phase Chronic Myelogenous Leukemia, BCR-ABL1 Positive | Philadelphia Chromosome Positive, BCR-ABL1 Positive Chronic Myelogenous Leukemia

United States
The First Affiliated Hospital of Soochow University

Recruiting

Flumatinib Versus Nilotinib for Newly Diagnosed Chronic Phase Chronic Myeloid Leukemia

CML, Chronic Phase; TKI

China
University of California, San Francisco
American Society of Hematology

Completed

A Distress Reduction Intervention for Patients With BCR-ABL-Negative MPNs or CML on Tyrosine Kinase Inhibitors

Chronic Myeloid Leukemia | Chronic Phase Chronic Myelogenous Leukemia | Myeloproliferative Neoplasm

United States
M.D. Anderson Cancer Center
National Cancer Institute (NCI)

Active, not recruiting

Dasatinib and Venetoclax in Treating Patients With Philadelphia Chromosome Positive or BCR-ABL1 Positive Early Chronic Phase Chronic Myelogenous Leukemia

Chronic Phase Chronic Myelogenous Leukemia, BCR-ABL1 Positive | Philadelphia Chromosome Positive, BCR-ABL1 Positive Chronic Myelogenous Leukemia

United States
National Taiwan University Hospital

Completed

Application of Wearable Devices to Build a Self-Management Model in Chronic Kidney Disease Patients

Chronic Kidney Disease stage4 | Chronic Kidney Disease stage3 | Chronic Kidney Disease Stage 2 | Chronic Kidney Disease Stage 1

Taiwan
Consorci Sanitari de l'Alt Penedès i Garraf

Recruiting

Radiofrequency Ablation for the Treatment of Post-knee Arthroplasty Chronic Pain. (CSAPG-37)

Chronic Post Operative Pain | Chronic Post-surgical Pain | Chronic Knee Pain

Spain
University of Pennsylvania
Teleflex; Arrow International

Completed

VectorFlow Tunneled Dialysis Catheter (TDC) Versus Palindrome TDC (TDC)

Renal Failure Chronic Requiring Hemodialysis | Chronic Renal Insufficiency

United States

Clinical Trials on Polmonite eosinofila cronica

Sponsors and Collaborators

Medical Conditions

Drug Interventions

CROs by country

CROs in Croatia

Conditions

Rare Diseases

Drug Interventions

Dietary Supplements

Sponsor/Collaborators

Locations